(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.73%) $79.57
(5.58%) $2.31
(1.27%) $2 351.90
(3.48%) $28.56
(0.85%) $993.00
(-0.28%) $0.927
(-0.44%) $10.84
(-0.21%) $0.798
(0.88%) $92.55
Quarter results today
(amc 2024-05-09)
Expected move: +/- 9.78%
0.58% $ 8.64
@ $8.61
Emitido: 9 may 2024 @ 14:39
Retorno: 0.35%
Señal anterior: may 9 - 14:16
Señal anterior:
Retorno: 0.76 %
Live Chart Being Loaded With Signals
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery...
Stats | |
---|---|
Volumen de hoy | 2.72M |
Volumen promedio | 6.45M |
Capitalización de mercado | 1.99B |
EPS | $0 ( 2024-02-26 ) |
Próxima fecha de ganancias | ( $-0.430 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.47 |
ATR14 | $0.225 (2.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Gibson Christopher | Sell | 21 296 | Class B Common Stock |
2024-05-01 | Gibson Christopher | Sell | 25 000 | Class A Common Stock |
2024-05-01 | Gibson Christopher | Sell | 50 000 | Class A Common Stock |
2024-05-02 | Gibson Christopher | Buy | 21 296 | Class A Common Stock |
2024-05-02 | Gibson Christopher | Sell | 21 296 | Class A Common Stock |
INSIDER POWER |
---|
38.37 |
Last 99 transactions |
Buy: 2 817 271 | Sell: 1 191 870 |
Volumen Correlación
Recursion Correlación
10 Correlaciones Más Positivas | |
---|---|
PLXP | 0.893 |
LUMO | 0.879 |
VIRX | 0.876 |
FATE | 0.874 |
STRC | 0.867 |
GROM | 0.859 |
HOOK | 0.859 |
CLEU | 0.857 |
SNCE | 0.851 |
QTEK | 0.85 |
10 Correlaciones Más Negativas | |
---|---|
XOMAO | -0.832 |
CCRC | -0.827 |
XOMAP | -0.825 |
LUNA | -0.824 |
ITMR | -0.821 |
LRFC | -0.821 |
ACAHU | -0.814 |
AVEO | -0.813 |
MICT | -0.813 |
BNIXU | -0.811 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Recursion Correlación - Moneda/Commodity
Recursion Finanzas
Annual | 2023 |
Ingresos: | $44.58M |
Beneficio Bruto: | $-6.51M (-14.61 %) |
EPS: | $-1.580 |
FY | 2023 |
Ingresos: | $44.58M |
Beneficio Bruto: | $-6.51M (-14.61 %) |
EPS: | $-1.580 |
FY | 2022 |
Ingresos: | $39.68M |
Beneficio Bruto: | $-8.59M (-21.66 %) |
EPS: | $-1.360 |
FY | 2021 |
Ingresos: | $10.18M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.658 |
Financial Reports:
No articles found.
Recursion
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico